- Home
- PMCB vs SCNX Comparison
PMCB vs SCNX Comparison
Compare PMCB & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMCB
- SCNX
- Stock Information
- Founded
- PMCB 1996
- SCNX 2010
- Country
- PMCB United States
- SCNX United States
- Employees
- PMCB N/A
- SCNX N/A
- Industry
- PMCB Biotechnology: Biological Products (No Diagnostic Substances)
- SCNX Other Pharmaceuticals
- Sector
- PMCB Health Care
- SCNX Health Care
- Exchange
- PMCB Nasdaq
- SCNX Nasdaq
- Market Cap
- PMCB 15.8M
- SCNX 13.1M
- IPO Year
- PMCB N/A
- SCNX 2020
- Fundamental
- Price
- PMCB $1.77
- SCNX $7.16
- Analyst Decision
- PMCB
- SCNX
- Analyst Count
- PMCB 0
- SCNX 0
- Target Price
- PMCB N/A
- SCNX N/A
- AVG Volume (30 Days)
- PMCB 37.6K
- SCNX 13.1K
- Earning Date
- PMCB 09-17-2024
- SCNX 11-10-2024
- Dividend Yield
- PMCB N/A
- SCNX N/A
- EPS Growth
- PMCB N/A
- SCNX N/A
- EPS
- PMCB 0.54
- SCNX N/A
- Revenue
- PMCB N/A
- SCNX N/A
- Revenue This Year
- PMCB N/A
- SCNX N/A
- Revenue Next Year
- PMCB N/A
- SCNX N/A
- P/E Ratio
- PMCB $3.31
- SCNX N/A
- Revenue Growth
- PMCB N/A
- SCNX N/A
- 52 Week Low
- PMCB $1.39
- SCNX $3.69
- 52 Week High
- PMCB $2.58
- SCNX $44.56
- Technical
- Relative Strength Index (RSI)
- PMCB 48.90
- SCNX N/A
- Support Level
- PMCB $1.72
- SCNX N/A
- Resistance Level
- PMCB $2.06
- SCNX N/A
- Average True Range (ATR)
- PMCB 0.28
- SCNX 0.00
- MACD
- PMCB -0.00
- SCNX 0.00
- Stochastic Oscillator
- PMCB 38.24
- SCNX 0.00
About PMCB PharmaCyte Biotech Inc.
PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.